Business Context and Reporting Period
This Form 8-K filing by NanoVibronix, Inc. (trading symbol: NAOV) reports a material corporate action dated March 12, 2025. The filing details the implementation of a reverse stock split approved by stockholders at a special meeting on February 24, 2025.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on capital structure adjustments.
Material Changes
- Reverse Stock Split: The Company effected a 1-for-11 reverse stock split of its common stock, effective March 13, 2025, at 4:05 p.m. (Delaware time).
- Share Count Reduction: Outstanding shares decreased from 8,716,327 to approximately 792,394 shares.
- Fractional Shares: No fractional shares were issued; any fractional entitlements were rounded up to the next whole number.
- Authorized Shares: The total number of authorized shares remains unchanged at 40,000,000.
- Equity Awards: Proportionate adjustments were made to exercise prices and share counts for outstanding awards under the 2024 and 2014 Long-Term Incentive Plans.
- Trading Details: Trading on the Nasdaq Capital Market resumed on a split-adjusted basis on March 14, 2025, under the symbol "NAOV" with a new CUSIP number (63008J702).
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance, management commentary on future operations, or specific risk factors beyond the standard incorporation by reference to the Certificate of Amendment and the definitive proxy statement filed on January 27, 2025.
Investor Verification Checklist
- Verify the new CUSIP number (63008J702) for accurate trade execution.
- Confirm the adjusted number of shares held in brokerage accounts post-split.
- Review the impact of the 1-for-11 split on the exercise price of any held stock options or warrants.
- Check the definitive proxy statement (filed January 27, 2025) for the full rationale behind the split.